Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1995Annals of Neurology

Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRuth MotterCalifornia Department of Public HealthCVCarmen Vigo‐PelfreyAthena Group (United States)DKDora KholodenkoAthena Group (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Motter et al. (1995) studied this question.

synapsesocial.com/papers/6a656d9d2cfb7e4d32f0c704https://doi.org/10.1002/ana.410380413
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diagnosis of Alzheimer's Disease1985 · 2,508 citations
  2. 2Cerebral Blood Flow in Dementia1975 · 3,206 citations
  3. 3Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease1995 · 226 citations
  4. 4Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid1993 · 386 citations
  5. 5Clinical-Neuropathological Correlations in Alzheimer's Disease and Related Dementias1994 · 410 citations